Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2024-10-01 History
Report ID 235134
Drug Identification Number 02362619
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.25G 2.00G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 X 2.25 G VIALS
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-09-06
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2024-10-01
Company comments The resupply date is TBD.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2024-10-01 French Compare
v9 2024-10-01 English Compare
v8 2024-09-07 English Compare
v7 2024-08-14 French Compare
v6 2024-08-14 English Compare
v5 2024-08-14 French Compare
v4 2024-08-14 English Compare
v3 2024-08-14 English Compare
v2 2024-08-12 French Compare
v1 2024-08-12 English Compare

Showing 1 to 10 of 10